Arcadia Biosciences, Inc. (RKDA)
0.4726
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.4653
-0.01
(-1.54%)
Pre-Market: 20:00
Arcadia Biosciences Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.0024 |
| March 31, 2025 | 0.0024 |
| December 31, 2024 | 0.0249 |
| September 30, 2024 | 0.0336 |
| June 30, 2024 | 0.049 |
| March 31, 2024 | 0.0774 |
| December 31, 2023 | 0.0784 |
| September 30, 2023 | 0.0818 |
| June 30, 2023 | 0.0853 |
| March 31, 2023 | 0.1054 |
| December 31, 2022 | 0.0959 |
| September 30, 2022 | 0.09 |
| June 30, 2022 | 0.093 |
| March 31, 2022 | 0.0907 |
| December 31, 2021 | 0.1059 |
| September 30, 2021 | 0.0956 |
| June 30, 2021 | 0.1901 |
| March 31, 2021 | 0.1611 |
| December 31, 2020 | 0.3373 |
| September 30, 2020 | 0.8446 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.7512 |
| March 31, 2020 | 0.5446 |
| December 31, 2019 | 0.2906 |
| September 30, 2019 | 0.1621 |
| June 30, 2019 | 0.2659 |
| March 31, 2019 | 3.705 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 1.709 |
| March 31, 2017 | 1.370 |
| December 31, 2016 | 1.132 |
| September 30, 2016 | 0.9115 |
| June 30, 2016 | 0.7999 |
| March 31, 2016 | 0.7041 |
| December 31, 2015 | 0.6198 |
| September 30, 2015 | 0.5823 |
| June 30, 2015 | 0.5319 |
| March 31, 2015 | -2.182 |
| December 31, 2014 | -8.517 |
| December 31, 2013 | -0.9109 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | -0.1684 |
| PMGC Holdings, Inc. | 0.8507 |
| Archer-Daniels-Midland Co. | 0.3963 |
| Alico, Inc. | 0.8148 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.893M |
| Total Liabilities (Quarterly) | 5.26M |
| Shareholders Equity (Quarterly) | 0.633M |
| Current Ratio | 3.487 |
| Net Debt Paydown Yield | 0.28% |